The deal would push the Japanese firm into the top 10 global drug firms as it searches for new growth

Japan’s Takeda clinches US$62 billion deal to buy rival drug maker Shire

The deal would push the Japanese firm into the top 10 global drug firms as it searches for new growth

Topic |   Mergers & Acquisitions

TOP PICKS

The deal would push the Japanese firm into the top 10 global drug firms as it searches for new growth
READ FULL ARTICLE